AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies
US11408899B2 · kind B2 · utility
0Cited by
0References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2014 |
| Grant date | Aug 9, 2022 |
| Priority date | — |
| Expiry date | Jul 11, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Virus vectors, virus particles, and methods and uses of screening for, detecting, analyzing and determining amounts of virus antibody, or neutralizing antibody activity of samples are provided. Such virus vectors, virus particles, and methods and uses are applicable to a broad range of virus types, such as lentiviruses, adenovirus, and adeno-associated virus (AAV) serotypes. Methods and uses include virus antibody screening, such as anti-virus immunoglobulins screened for, detected, analyzed and amounts determined.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.